Moran Wealth Management »

BioMarin Pharmaceutical shares owned by Moran Wealth Management

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Moran Wealth Management from 13F filings

Historical chart of Moran Wealth Management investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Moran Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Moran Wealth Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $227k 2.4k 96.42

More positions owned by Moran Wealth Management

Cadence Design Systems (CDNS)
Parker-Hannifin Corporation (PH)
Novo-nordisk A S Adr (NVO)
Trane Technologies SHS (TT)
Merck & Co (MRK)
Microsoft Corporation (MSFT)
Williams-Sonoma (WSM)
EOG Resources (EOG)
Celanese Corporation (CE)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Lockheed Martin Corporation (LMT)
Linde SHS (LIN)
JPMorgan Chase & Co. (JPM)
Bhp Group Sponsored Ads (BHP)
Exxon Mobil Corporation (XOM)

View all positions for Moran Wealth Management

Top funds holding BioMarin Pharmaceutical

PRIMECAP Management Company
Vanguard Group
Dodge & Cox
Barclays
Viking Global Investors
venBio Select Advisor
Deutsche Bank Aktiengesellschaft
Norges Bank Investment Management
Elliott Investment Management
Henderson Group
Bank of New York Mellon
Jpmorgan Chase & Co
Bank of America Corporation
Nomura Holdings
Parnassus Investments

View all funds holding BioMarin Pharmaceutical